5-APDB

5-APDB
Clinical data
Routes of; administration	Oral
ATC code	None;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule I; DE: NpSG (Industrial and scientific use only); UK: Class B;
Identifiers
	IUPAC name 1-(2,3-Dihydro-1-benzofuran-5-yl)propan-2-amine;
CAS Number	152624-03-8 ;
PubChem CID	192601;
ChemSpider	167143 ;
UNII	UI10BAJ8SH;
CompTox Dashboard (EPA)	DTXSID70934560 ;
Chemical and physical data
Formula	C11H15NO
Molar mass	177.247 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Cl.CC(N)Cc1cc2CCOc2cc1;
	InChI InChI=1S/C11H15NO.ClH/c1-8(12)6-9-2-3-11-10(7-9)4-5-13-11;/h2-3,7-8H,4-6,12H2,1H3;1H ; Key:BZKLFXQUBIRXAK-UHFFFAOYSA-N ;
	(what is this?) (verify)

5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA.

Clinical data

Routes of administration	Oral
ATC code	None
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics) CA: Schedule I DE: NpSG (Industrial and scientific use only) UK: Class B
Identifiers
IUPAC name 1-(2,3-Dihydro-1-benzofuran-5-yl)propan-2-amine
CAS Number	152624-03-8^N
PubChem CID	192601
ChemSpider	167143^N
UNII	UI10BAJ8SH
CompTox Dashboard (EPA)	DTXSID70934560
Chemical and physical data
Formula	C₁₁H₁₅NO
Molar mass	177.247 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES Cl.CC(N)Cc1cc2CCOc2cc1
InChI InChI=1S/C11H15NO.ClH/c1-8(12)6-9-2-3-11-10(7-9)4-5-13-11;/h2-3,7-8H,4-6,12H2,1H3;1H^Y Key:BZKLFXQUBIRXAK-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)